Department of Nutrition, Gilling’s School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Auto-generated profile, based on publicly available information
Rafia Virk
Department of Nutrition, Gilling’s School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Obesity exacerbates inflammation upon lung injury; however, the mechanisms by which obesity primes pulmonary dysregulation prior to external injury are not well studied. Herein, we tested the hypothesis that obesity dysregulates pulmonary PUFA metabolism that is central to inflammation initiation and resolution. We first show that a high-fat diet (HFD) administered to C57BL/6J mice increased the relative abundance of pulmonary PUFA-containing triglycerides and the concentration of PUFA-derived oxylipins (particularly prostaglandins and hydroxyeicosatetraenoic acids), independent of an increase in total pulmonary PUFAs, prior to onset of pulmonary inflammation. Experiments with a genetic model of obesity (ob/ob) generally recapitulated the effects of the HFD on the pulmonary oxylipin signature. Subsequent pulmonary next-generation RNA sequencing identified complex and unique transcriptional regulation with the HFD. We found the HFD increased pathways related to glycerophospholipid metabolism and immunity, including a unique elevation in B cell differentiation and signaling. Furthermore, we conducted computational integration of lipidomic with transcriptomic data. These analyses identified novel HFD-driven networks between glycerophospholipid metabolism and B cell receptor signaling with specific PUFA-derived pulmonary oxylipins. Finally, we confirmed the hypothesis by demonstrating that the concentration of pulmonary oxylipins, in addition to inflammatory markers, were generally increased in mice consuming a HFD upon ozone-induced acute lung injury. Collectively, these data show that a HFD dysregulates pulmonary PUFA metabolism prior to external lung injury, which may be a mechanism by which obesity primes the lungs to respond poorly to infectious and/or inflammatory challenges.
1 November 2025 in American Journal of Respiratory Cell and Molecular Biology
Ozone (O3) is an air pollutant that induces pulmonary inflammation and injury, leading to increased susceptibility and exacerbation of chronic lung diseases. Furthermore, ambient O3 concentrations are expected to rise with increasing global temperatures. Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated fatty acid found primarily in oily fish that reduces inflammation and enhances the resolution of inflammation. This is attributed partially to DHA-derived oxylipins termed specialized proresolving mediators that have antiinflammatory and/or proresolving properties. However, whether dietary DHA protects the lungs from O3-induced inflammation and injury is unclear. We hypothesized that dietary DHA supplementation increases pulmonary specialized proresolving mediators and thereby decreases O3-induced pulmonary inflammation. To test this, C57BL/6J mice were fed a control diet or a DHA-enriched diet (2% kcal from DHA) for 6 weeks, exposed to filtered air or 1 ppm O3 for 3 hours (comparable with an O3 action day for humans), and necropsied 24 or 48 hours after exposure. DHA supplementation reduced airspace neutrophilia, decreased cytokine production, and promoted transcriptomic signatures for leukocyte chemotaxis and fatty acid oxidation. Furthermore, dietary DHA increased pulmonary DHA and its oxylipins while decreasing proinflammatory omega-6 polyunsaturated fatty acids and their oxylipins. Oropharyngeal aspiration of DHA oxylipins monohydroxylated 14-hydroxy-DHA and maresin 1 decreased O3-induced airspace neutrophilia and reduced bone marrow–derived macrophage production of neutrophil chemokines Cxcl1 and Cxcl2. These findings reveal that dietary DHA protects the lungs from O3 exposure by driving monohydroxylated 14-hydroxy-DHA and maresin 1 production, which reduces neutrophil-recruiting chemokine production by macrophages. This pathway highlights a potential therapeutic dietary approach for mitigating air pollution–induced pulmonary inflammation.
Ozone (O 3 ) is a toxic air pollutant that causes pulmonary inflammation, neutrophil recruitment, and lung injury. Part of the inflammatory response to O 3 includes altered expression of formyl peptide receptor 2 (ALX/FPR2), a G protein‐coupled receptor expressed primarily in immune cells. ALX/FPR2 is considered either anti‐inflammatory/proresolving or proinflammatory depending on its ligands, which include lipoxin A4 or serum amyloid A (SAA). While the anti‐inflammatory/proresolving lipoxin A4 ligand has been well studied, there remains a significant knowledge gap in the interaction between proinflammatory SAA and ALX/FPR2. To date, SAA has been shown to increase neutrophil recruitment through ALX/FPR2 and is increased systemically after O 3 exposure. However, it is unclear if pulmonary SAA signals through ALX/FPR2 during the O 3 ‐induced inflammatory response. We hypothesized that ALX/FPR2‐SAA signaling is required to initiate neutrophil recruitment to the lungs following O 3 exposure. To test this hypothesis, ALX/FPR2 wild type (FPR2 +/+ ) or knockout (FPR2 −/− ) mice were exposed to filtered air (FA) or 1 ppm O 3 for 3 h. Pulmonary inflammation was assessed 6, 24, and 48 h following O 3 exposure. FPR2 −/− mice exhibited impaired neutrophil recruitment at 6 and 24 h after O 3 exposure. In addition, FPR2 −/− mouse pulmonary SAA expression was significantly increased after O 3 exposure compared to FPR2 +/+ mice. FPR2 +/+ mice dosed with SAA via oropharyngeal aspiration had increased pulmonary neutrophils, while neutrophils were not increased in FPR2 −/− mice. Taken together, these data indicate that ALX/FPR2 may contribute to SAA‐induced pulmonary neutrophilia following O 3 exposure.
The inflammation resolution receptor lipoxin A4/formyl peptide receptor 2 (ALX/FPR2) plays a critical role in immune regulation by binding select oxylipins derived from n-6 and n-3 polyunsaturated fatty acids (PUFAs). While ALX/FPR2 is implicated in controlling inflammation initiation and resolution, its specific role in pulmonary inflammatory responses remains unclear. In this study, we investigated how genetic deletion of Alx/Fpr2 controls oxylipin levels, immune cell populations, and inflammatory cytokines under conditions of homeostasis and injury. Alx/Fpr2 knockout (KO) mice exhibited normal food intake and weight gain but showed impaired glucose and lipid metabolism. Targeted lipidomic analyses by liquid chromatography–tandem mass spectrometry revealed elevated pulmonary concentrations of n-6 and n-3 PUFA–derived oxylipins in KO mice compared to controls. Flow cytometry further demonstrated increased lung infiltration of NK cells, monocytes, and lymphoid cells, indicating a proinflammatory state in the absence of injury. Following 24 h of LPS-induced acute lung injury, IL-1β levels were elevated in KO mice, but pulmonary histopathology, immune cell numbers, and oxylipin levels were comparable to those of controls. These results suggested a protective role of ALX/FPR2 upon acute lung injury, which led us to further investigate the role of ALX/FPR2 upon 72 h of lung injury. Indeed, Alx/Fpr2 KO mice showed reduced bronchoalveolar lavage protein concentration and lower levels of IL-6 and TNF-α. Collectively, these findings demonstrate that ALX/FPR2 deficiency promotes basal pulmonary inflammation but protects against prolonged injury-induced inflammation, highlighting the context-dependent role of this receptor in pulmonary inflammation.